COVID-19 Ad Intervention

Social Distance Clinical Trial

Official title:

COVID-19 Ad Intervention for Social Distancing

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04555122
• Other study ID #: IRB# 20205923
• Status: Withdrawn
• Phase: N/A
• Start date: October 1, 2021
• Est. completion date: July 28, 2022

Study information

• Verified date: May 2023
• Source: University of California, Irvine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will provide advertisements to (de-identified) participants and track (de-identified) movement patterns to learn whether the ads increase adherence to stay-at-home orders.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: July 28, 2022
• Est. primary completion date: May 28, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older (as identified by company running advertisements); recent visit to a non-essential location; agreed to terms and conditions of websites allowing advertisements Exclusion Criteria: -

Related Conditions & MeSH terms

• Social Distance

Intervention

Behavioral:
• Social Distancing Advertisements
Participants will receive 3 types of advertisements to increase social distancing/staying at home.

Locations

Country	Name	City	State
United States	UC Irvine	Irvine	California

Sponsors (3)

Lead Sponsor	Collaborator
University of California, Irvine	City University of Hong Kong, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mobility	Amount of time that participants are outside of their primary location/home	7 days